دورية أكاديمية
أعرض في EDS

Systematic review of surveillance systems for AMR in Africa.

التفاصيل البيبلوغرافية
العنوان: Systematic review of surveillance systems for AMR in Africa.
المؤلفون: Okolie OJ; Department of Applied Sciences, University of the West of England Bristol, Bristol, BS16 1QY, UK., Igwe U; Department of Applied Sciences, University of the West of England Bristol, Bristol, BS16 1QY, UK., Ismail SU; School of Health and Social Wellbeing, University of the West of England, Bristol, Glenside Campus, Blackberry Hill, Stapleton, Bristol, BS16 1DD, UK., Ighodalo UL; Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, Federal University Oye-Ekiti, Oye-Are Road, Oye-Ekiti, Ekiti State, Nigeria., Adukwu EC; Department of Applied Sciences, University of the West of England Bristol, Bristol, BS16 1QY, UK.
المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Dec 23; Vol. 78 (1), pp. 31-51.
نوع المنشور: Journal Article; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
أسماء مطبوعة: Publication: 1997- : London : Oxford University Press
Original Publication: London, New York, Academic Press.
مواضيع طبية MeSH: Anti-Infective Agents* , Policy*, Humans ; Africa/epidemiology
مستخلص: Aims: Surveillance is a useful tool for tracking antimicrobial resistance (AMR) trends, patterns, therapeutic and policy interventions. Proper correlation of surveillance data gives meaningful insight into the underlying epidemiology and facilitates development of rational interventions. This comprehensive review aims to identify, classify and assess gaps in Global Antimicrobial Resistance and Use Surveillance System (GLASS) reporting and national action plan (NAP) implementation in Africa.
Methods: Articles published in English were searched across five electronic databases (PubMed, Scopus, Embase, AJOL and Cochrane) and grey literature. Articles were screened against inclusion/exclusion criteria and data from eligible studies were retrieved and analysed. This systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on 31 July 2020 under protocol CRD42020192165.
Results: Of the 4304 records found, only 32 met the initial inclusion criteria (4 peer reviews and 28 were grey literature). From these records, 41 surveillance systems were identified (30 national and 11 transnational). After final review of reported outcomes, only 23 national surveillance systems met the inclusion criteria. Indicators recorded from these systems shows lack of external quality assessment (EQA) in some systems and limited reporting of parameters such as infection origin, patient population and pathogen types.
Conclusions: The outcome of the review shows that although AMR surveillance has been implemented in 23 out of the 47 countries in the region, a number of limitations exist in the surveillance methods and reporting protocols that can impair the usefulness, validity and trustworthiness of data generated from these surveillance systems.
(© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.)
References: J Antimicrob Chemother. 2018 Jun 1;73(6):1464-1478. (PMID: 29554263)
Worldviews Evid Based Nurs. 2006;3(2):55-61. (PMID: 17040510)
Lancet Infect Dis. 2018 Dec;18(12):e368-e378. (PMID: 30172580)
Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000010. (PMID: 17443631)
Int J Pharm Pract. 2018 Feb;26(1):85-89. (PMID: 28544416)
BMC Infect Dis. 2019 Mar 25;19(1):281. (PMID: 30909883)
Int J Antimicrob Agents. 2017 Nov;50(5):629-639. (PMID: 28705671)
BMC Infect Dis. 2017 Sep 11;17(1):616. (PMID: 28893183)
Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63. (PMID: 33789754)
Emerg Infect Dis. 2002 May;8(5):496-502. (PMID: 11996685)
J Antimicrob Chemother. 2019 Mar 1;74(3):541-546. (PMID: 30544186)
Clin Microbiol Infect. 2018 Feb;24(2):105-109. (PMID: 28750921)
J Clin Microbiol. 2019 Jan 30;57(2):. (PMID: 30333126)
BMJ Glob Health. 2020 Nov;5(11):. (PMID: 33239336)
BMJ. 2021 Mar 29;372:n160. (PMID: 33781993)
Curr Treat Options Infect Dis. 2020;12(3):191-201. (PMID: 32874140)
Clin Microbiol Infect. 2017 Jan;23(1):2-22. (PMID: 27890457)
Trop Med Infect Dis. 2019 Dec 13;4(4):. (PMID: 31847247)
Int J Evid Based Healthc. 2015 Sep;13(3):132-40. (PMID: 26360830)
ACP J Club. 1995 Nov-Dec;123(3):A12-3. (PMID: 7582737)
J Med Microbiol. 2020 May;69(5):657-669. (PMID: 31665100)
Annu Rev Public Health. 2014;35:29-45. (PMID: 24188053)
Front Public Health. 2020 Aug 27;8:454. (PMID: 32974264)
J Public Health (Oxf). 2017 Mar 1;39(1):8-13. (PMID: 26944074)
BMC Public Health. 2015 May 01;15:448. (PMID: 25928645)
Int J Evid Based Healthc. 2015 Sep;13(3):179-87. (PMID: 26262565)
PLoS Med. 2016 Nov 29;13(11):e1002184. (PMID: 27898664)
Afr J Lab Med. 2018 Dec 06;7(2):830. (PMID: 30568906)
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):47-50. (PMID: 21808439)
Bull World Health Organ. 2019 Apr 1;97(4):283-289. (PMID: 30940985)
Wellcome Open Res. 2017 Sep 26;2:91. (PMID: 29181453)
BMJ. 2020 Jan 16;368:l6890. (PMID: 31948937)
المشرفين على المادة: 0 (Anti-Infective Agents)
تواريخ الأحداث: Date Created: 20221013 Date Completed: 20230814 Latest Revision: 20230814
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9780554
DOI: 10.1093/jac/dkac342
PMID: 36227707
قاعدة البيانات: MEDLINE
الوصف
تدمد:1460-2091
DOI:10.1093/jac/dkac342